← Leaderboards
Sean P. J. Whelan
Washington University
$36,954,740
Attributed
$41,745,235
Total exposure
15
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $58.4M · FY2005–25$100M$75M$50M$25M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$119,608,662 · 18
By mechanism
U19$85,821,637 · 6
R01$14,874,686 · 5
P01$10,707,246 · 1
R37$5,387,695 · 1
U54$1,531,716 · 1
T32$1,103,758 · 1
Top collaborators
- Tomas Kirchhausen5 shared
- Eric Lieberman Greer4 shared
- Adrianus Cm Boon3 shared
- Daved H Fremont3 shared
- Michael S. Diamond2 shared
- Anne Moscona1 shared
- Rino Rappuoli1 shared
Most similar at Washington University
Same institution · by research overlap
- Adrianus Cm Boon$7,930,780
- Daved H Fremont$19,011,013
- Ali Hassan Ellebedy$14,119,121
- David Wang$34,713,611
- Rino Rappuoli$0
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsVirusStructureCellsVesicular Stomatitis Indiana VirusViralBiochemicalGeneticInfectionAntiviral AgentsIn VitroVaccinesInsightMessenger RnaRna VirusesVirus DiseasesReagentMethyltransferaseBiologyInterestMethylationMapsEnsureRecombinants
Grant awards (70)
The Development and Evaluation of Pan-Coronavirus Vaccines$2,716,452
P01 · FY2025 · AI
Mechanism and Inhibition of SARS-CoV-2 Entry$752,346
R01 · FY2025 · AI · contact PI
Mechanism and Inhibition of Thogotovirus Entry$700,837
R01 · FY2025 · AI
Vaccines and Therapeutic Antibodies to Respiro, Rubula, Peribunya and Phenuiviridae (R2P2)-ReVAMPP$44,108,652
U19 · FY2024 · AI · contact PI
Prototype strategy for vaccines and antibodies to Peribunyaviridae$6,793,772
U19 · FY2024 · AI · contact PI
Core A: Administrative Core$4,737,502
U19 · FY2024 · AI · contact PI
Cap specific N6 methylation of viral mRNA by the cellular methyltransferase PCIF1$752,625
R01 · FY2024 · AI · contact PI
Mechanism and Inhibition of SARS-CoV-2 Entry$752,346
R01 · FY2024 · AI · contact PI
Mechanism and Inhibition of Thogotovirus Entry$688,397
R01 · FY2024 · AI
RNA Processing in Non-Segmented Minus-Strand RNA Viruses$561,330
R37 · FY2024 · AI · contact PI
Cap specific N6 methylation of viral mRNA by the cellular methyltransferase PCIF1$752,625
R01 · FY2023 · AI · contact PI
Mechanism and Inhibition of SARS-CoV-2 Entry$752,346
R01 · FY2023 · AI · contact PI
Mechanism and Inhibition of Thogotovirus Entry$695,774
R01 · FY2023 · AI
RNA Processing in Non-Segmented Minus-Strand RNA Viruses$561,330
R37 · FY2023 · AI · contact PI
The Development and Evaluation of Pan-Coronavirus Vaccines$7,990,794
P01 · FY2022 · AI
Cap specific N6 methylation of viral mRNA by the cellular methyltransferase PCIF1$752,625
R01 · FY2022 · AI · contact PI
Mechanism and Inhibition of SARS-CoV-2 Entry$752,346
R01 · FY2022 · AI · contact PI
RNA Processing in Non-Segmented Minus-Strand RNA Viruses$561,330
R37 · FY2022 · AI · contact PI
Cap specific N6 methylation of viral mRNA by the cellular methyltransferase PCIF1$767,000
R01 · FY2021 · AI · contact PI
Mechanism and Inhibition of SARS-CoV-2 Entry$766,721
R01 · FY2021 · AI · contact PI
RNA Processing in Non-Segmented Minus-Strand RNA Viruses$561,330
R37 · FY2021 · AI · contact PI
RNA Processing in Non-Segmented Minus-Strand RNA Viruses$560,736
R37 · FY2020 · AI · contact PI
RNA Processing in Non-Segmented Minus-Strand RNA Viruses$503,415
R37 · FY2019 · AI · contact PI
Small molecule inhibitors of enveloped virus entry$3,986,024
U19 · FY2018 · AI · contact PI
Discovery of new cellular targets for small-molecule inhibition of enveloped vir$953,766
U19 · FY2018 · AI · contact PI
RNA Processing in Non-Segmented Minus-Strand RNA Viruses$503,415
R37 · FY2018 · AI · contact PI
Molecular Basis of Viral Infectivity$468,517
T32 · FY2018 · AI · contact PI
Administrative$257,107
U19 · FY2018 · AI · contact PI
Small molecule inhibitors of enveloped virus entry$5,076,989
U19 · FY2017 · AI · contact PI
Discovery of new cellular targets for small-molecule inhibition of enveloped vir$1,248,634
U19 · FY2017 · AI · contact PI
RNA Processing in Non-Segmented Minus-Strand RNA Viruses$503,415
R37 · FY2017 · AI · contact PI
Administrative$483,499
U19 · FY2017 · AI · contact PI
Molecular Basis of Viral Infectivity$469,611
T32 · FY2017 · AI · contact PI
Molecular Basis of Viral Infectivity$6,938
T32 · FY2017 · AI · contact PI
Small molecule inhibitors of enveloped virus entry$5,357,643
U19 · FY2016 · AI · contact PI
Discovery of new cellular targets for small-molecule inhibition of enveloped vir$1,441,843
U19 · FY2016 · AI · contact PI
Administrative$984,760
U19 · FY2016 · AI · contact PI
RNA Processing in Non-Segmented Minus-Strand RNA Viruses$503,415
R37 · FY2016 · AI · contact PI
Molecular Basis of Viral Infectivity$158,692
T32 · FY2016 · AI · contact PI
Small molecule inhibitors of enveloped virus entry$4,204,548
U19 · FY2015 · AI · contact PI
Discovery of new cellular targets for small-molecule inhibition of enveloped vir$716,172
U19 · FY2015 · AI · contact PI
RNA Processing in Non-Segmented Minus-Strand RNA Viruses$567,979
R37 · FY2015 · AI · contact PI
RNA Processing in Non-Segmented Minus-Strand RNA Viruses$271,171
R01 · FY2015 · AI · contact PI
Administrative$216,972
U19 · FY2015 · AI · contact PI
2015 Viruses and Cells Gordon Research Conference$5,000
R13 · FY2015 · AI · contact PI
Small molecule inhibitors of enveloped virus entry$4,422,325
U19 · FY2014 · AI · contact PI
Discovery of new cellular targets for small-molecule inhibition of enveloped vir$662,290
U19 · FY2014 · AI · contact PI
Molecular Mechanisms of Rhabdovirus Entry$413,330
R01 · FY2014 · AI · contact PI
RNA Processing in Non-Segmented Minus-Strand RNA Viruses$413,302
R01 · FY2014 · AI · contact PI
Administrative$169,139
U19 · FY2014 · AI · contact PI
Molecular Mechanisms of Rhabdovirus Entry$388,699
R01 · FY2013 · AI · contact PI
RNA Processing in Non-Segmented Minus-Strand RNA Viruses$388,674
R01 · FY2013 · AI · contact PI
Novel antiviral targets in Ebola and Marburg virus polymerases$314,279
U54 · FY2013 · AI · contact PI
Molecular Mechanisms of Rhabdovirus Entry$413,685
R01 · FY2012 · AI · contact PI
RNA Processing in Non-Segmented Minus-Strand RNA Viruses$413,658
R01 · FY2012 · AI · contact PI
Novel antiviral targets in Ebola and Marburg virus polymerases$247,710
U54 · FY2012 · AI · contact PI
Molecular Mechanisms of Rhabdovirus Entry$413,854
R01 · FY2011 · AI · contact PI
RNA Processing in Non-Segmented Minus-Strand RNA Viruses$413,829
R01 · FY2011 · AI · contact PI
Novel antiviral targets in Ebola and Marburg virus polymerases$324,553
U54 · FY2011 · AI · contact PI
ASM Conference on Viral Genome Replication$10,000
R13 · FY2011 · AI · contact PI
Molecular Mechanisms of Rhabdovirus Entry$418,201
R01 · FY2010 · AI · contact PI
RNA Processing in Non-Segmented Minus-Strand RNA Viruses$418,176
R01 · FY2010 · AI · contact PI
Novel antiviral targets in Ebola and Marburg virus polymerases$339,978
U54 · FY2010 · AI · contact PI
RNA processing in non-segmented minus-strand RNA viruses$315,326
R01 · FY2009 · AI · contact PI
Novel antiviral targets in Ebola and Marburg virus polymerases$305,196
U54 · FY2009 · AI · contact PI
Molecular Mechanisms of Rhabdovirus Entry$166,924
R56 · FY2009 · AI · contact PI
RNA processing in non-segmented minus-strand RNA viruses$315,326
R01 · FY2008 · AI · contact PI
RNA processing in non-segmented minus-strand RNA viruses$321,433
R01 · FY2007 · AI · contact PI
RNA processing in non-segmented minus-strand RNA viruses$331,034
R01 · FY2006 · AI · contact PI
RNA processing in non-segmented minus-strand RNA viruses$339,000
R01 · FY2005 · AI